CONCLUSION
Currently, there is an epidemic of prescription drug abuse, diversion, and overdose deaths not only in West Virginia but also across the country. The complexity of this crisis creates challenges for federal, state, and local governments as well as nongovernmental partners who must confront the growing impacts on the community.
Overprescribing opioids for more than a decade has contributed to prescription opioid addiction and led to a sharp increase in opioid addiction, which is associated with a significant increase in heroin abuse, health compromise, and overdose deaths. A multifaceted public health approach is necessary in order to effectively reduce opioid-related morbidity and mortality.
The opioid epidemic in this country has evolved and escalated along with an epidemic of chronic pain. With current evidence affirming that less-risky pain alternatives are just as effective as opioids for managing chronic pain, it is clear that there must be a cultural shift away from treating chronic pain with opioid medication.
Nurses are in a unique position to address this dual epidemic with the right clinical skills and knowledge in assessment and management of addiction risk and best practices for safe opioid prescribing. A comprehensive approach that supports safe and effective pain management without increasing patient risk for addiction must be priority in every clinical practice setting.
RESOURCES
CDC Clinical Practice Guideline for Prescribing Opioids for Pain
Controlled substance public disposal locations search utility
Drug overdose prevention in States
Opioid prescribing guideline resources (CDC)
Opioid safety: veteran/patient education (Veteran’s Administration)
Pain Assessment and Documentation Tool (PADT)
Risk Assessment and Mitigation Strategy (REMS) sample document
Screening and assessment tools chart (National Institute on Drug Abuse)
REFERENCES
NOTE: Complete URLs for references retrieved from online sources are provided in the PDF of this course.
American Academy of Family Physicians (AAFP). (2021). Safe use, storage, and disposal of opioid drugs. Retrieved from https://familydoctor.org
American Association of Nurse Anesthesiology (AANA). (2021). Signs and behaviors of impaired colleagues. Retrieved from https://www.aana.com
American Psychiatric Association. (2021). Help with addiction and substance use disorder. Retrieved from https://www.psychiatry.org
American Society of Addiction Medicine (ASAM). (2021). Definition of addiction. Retrieved from https://www.asam.org
American Society of Addiction Medicine (ASAM). (2012). Public policy statement on measures to counteract prescription drug diversion, misuse, and addiction. Retrieved from https://www.asam.org
Bazzo D, Crossno R, Galluzzi K, Havens C, Hudspeth RS, Rivenburgh D, Salsitz EA, & St. Marie B. (2019). Pain management and opioids: balancing risks and benefits. Medscape. Retrieved from https://www.medscape.org
Becker W & Starrels J. (2021). Prescription drug misuse: epidemiology, prevention, identification, and management. UpToDate. Retrieved from https://www.uptodate.com
Brummond PW, Chen DF, Churchill WW, Clark JS, Dillon KR, Eschenbacher L, et al. (2017). ASHP guidelines on prevention diversion of controlled substances. Am J Health Syst Pharm, 74(5), 325–48.
Centers for Disease Control and Prevention (CDC). (2022). Draft CDC clinical practice guideline for prescribing opioids—United States, 2022: overview of community engagement and public comment opportunities. Retrieved from https://www.regulations.gov
Centers for Disease Control and Prevention (CDC). (2021a). 2019 drug overdose death rates. Retrieved from https://www.cdc.gov
Centers for Disease Control and Prevention (CDC). (2021b). Commonly used terms. Retrieved from https://www.cdc.gov
Centers for Disease Control and Prevention (CDC). (2021c). NVSS vital statistics rapid release: provisional drug overdose death counts. Retrieved from https://www.cdc.gov
Centers for Disease Control and Prevention (CDC). (2021d). CDC Launches new education campaigns aimed at preventing drug overdose deaths. Retrieved from https://www.cdc.gov
Centers for Disease Control and Prevention (CDC). (2021e). Lifesaving naloxone. Retrieved from https://www.cdc.gov
Centers for Disease Control and Prevention (CDC). (2019). Drug diversion. Retrieved from https://www.cdc.gov
Centers for Disease Control and Prevention (CDC). (2017). Prevention for states. Retrieved from https://www.cdc.gov
Centers for Disease Control and Prevention (CDC). (2016). CDC guideline for prescribing opioids for chronic pain—United States, 2016. Retrieved from https://www.cdc.gov
Centers for Disease Control and Prevention (CDC). (n.d.-a). Prescription drug monitoring programs (PDMPs). Retrieved from https://www.cdc.gov
Centers for Disease Control and Prevention (CDC). (n.d.-b). Calculating total daily dose of opioids for safer dosage. Retrieved from https://www.cdc.gov
Dowell D, Ragan KR, Jones CM, Baldwin GT, & Chou R. (2022). CDC clinical practice guideline for prescribing opioids for pain—United States, 2022. MMWR Recomm Rep, 71(RR-3), 1–95. http://dx.doi.org/10.15585/mmwr.rr7103a
Khan U, Bloom RA, Nicell JA, & Laurenson JP. (2017). Risks associated with the environmental release of pharmaceuticals on the U.S. Food and Drug Administration “flush list.” Sci Total Environ, 609, 1023–40. doi:10.1016/j.scitotenv.2017.05.269
Maumus M, Mancini R, Zumsteg DM, & Mandali DK. (2020). Aberrant drug-related behavior monitoring. The Ochsner Journal, 20(4), 358–61. doi:10.31486/toj.20.0108. Retrieved from https://www.ncbi.nlm.nih.gov
Mumba MN. (2018). Employment implications of nurses going through peer assistance programs for substance use disorders. Archives of Psychiatric Nursing, 32(4), 561–7. doi:10.1016/j.apnu.2018.03.001
National Council State Boards of Nursing (NCSBN). (2018). A nurse managers’ guide to substance use disorder in nursing. Retrieved from https://www.ncsbn.org
National Institute of Neurologic Disorders and Stroke (NINDS). (2021). Chronic pain information page. Retrieved from https://www.ninds.nih.gov/p>
National Institute on Drug Abuse (NIDA). (2021). Overdose death rates. Retrieved from https://www.drugabuse.gov
National Institute on Drug Abuse (NIDA). (2020). Misuse of prescription drugs research report. Retrieved from https://www.drugabuse.gov
National Institute on Drug Abuse (NIDA). (2017). Commonly abused prescription drugs chart. Retrieved from http://www.drugabuse.gov
National Institute on Drug Abuse (NIDA). (n.d.). Sample patient agreement forms. Retrieved from https://www.drugabuse.gov
National Safety Council (NSC). (2019). For the first time, we’re more likely to die from accidental opioid overdose than motor vehicle crash. Retrieved from https://www.nsc.org
Nicholas M, Vlaeyen JWS, Rief W, Barke A, Aziz Q, Benoliel R, Cohen M, et al. (2019). IASP classification of chronic pain for ICD-11: chronic primary pain. PAIN, 160(1), 28–37. doi:10.1097/j.pain.0000000000001390
Pew Charitable Trusts. (2020). Expanded access to naloxone can curb opioid overdose deaths. Retrieved from https://www.pewtrusts.org
Prescription Behavior Surveillance System (PBSS), Brandeis University. (n.d.). Prescription behavior surveillance system. Retrieved from http://pdmpassist.org
Prescription Drug Monitoring Program Training and Technical Assistance Center (PDMP TTAC). (2021). Information sharing. Retrieved from https://www.pdmpassist.org
Protenus. (2021). 2021 diversion digest. Retrieved from https://www.protenus.com
Strickler GK, Kreiner PW, Halpin JF, Doyle E, & Paulozzi LJ. Opioid prescribing behaviors—Prescription Behavior Surveillance System, 11 States, 2010–2016. MMWR Surveill Summ, 69(SS-1), 1–14. doi:10.15585/mmwr.ss6901a1
Substance Abuse and Mental Health Services Administration (SAMHSA). (2021a). Key terms and definitions. Retrieved from https://www.samhsa.gov
Substance Abuse and Mental Health Services Administration (SAMHSA). (2021b). Naloxone. Retrieved from https://www.samhsa.gov
Substance Abuse and Mental Health Services Administration (SAMHSA). (2020). Key substance use and mental health indicators in the United States: results from the 2019 National Survey on Drug Use and Health (HHS Publication No. PEP20-07-01-001). Rockville, MD: Author. Retrieved from https://store.samhsa.gov
The Joint Commission (TJC). (2019). Quick safety: drug diversion and impaired health care workers. Retrieved from https://www.jointcommission.org
U.S. Department of Health & Human Services (U.S. DHHS). (2021). What is the U.S. opioid epidemic? Retrieved from https://www.hhs.gov
U.S. Department of Health & Human Services (U.S. DHHS). (2019). HHS guide for clinicians on the appropriate dosage reduction or discontinuation of long-term opioid analgesics. Retrieved from https://www.hhs.gov
U.S. Department of Veterans Affairs (VA). (2020). Staying safe on prescription opioids. Retrieved from https://www.mentalhealth.va.gov
U. S. Drug Enforcement Administration (DEA). (2021a). DEA national Rx take back. Retrieved from https://takebackday.dea.gov
U. S. Drug Enforcement Administration (DEA). (2021b). Counterfeit pills fact sheet. Retrieved from https://www.dea.gov
U.S. Drug Enforcement Administration (DEA). (2021c). Drug addiction in health care professionals. Retrieved from https://www.deadiversion.usdoj.gov
U.S. Drug Enforcement Administration (DEA). (2020a). Drugs of abuse: a DEA resource guide. Retrieved from https://www.dea.gov
U. S. Drug Enforcement Administration (DEA). (2020b). Stimulants. Retrieved from https://www.dea.gov
U.S. Food and Drug Administration (FDA). (2020a). Disposal of unused medicines: what you should know. Retrieved from https://www.fda.gov
U.S. Food and Drug Administration (FDA). (2020b). Drug disposal: FDA’s flush list for certain medicines. Retrieved from https://www.fda.gov
U.S. Food and Drug Administration (FDA). (2019). Risk evaluation and mitigation strategies—REMS. Retrieved from https://www.fda.gov
U.S. Food and Drug Administration (FDA). (2018). Drug disposal: dispose “non-flush list” medicine in the trash. Retrieved from https://www.fda.gov
West Virginia Department of Health and Human Resources (WV DHHR), Bureau for Public Health. (2021). Statewide standing order for the distribution of naloxone by eligible recipient organizations for opioid overdose prevention. Retrieved from https://dhhr.wv.gov
West Virginia Department of Health & Human Resources (WV DHHR), Office of Drug Control Policy. (2020). West Virginia 2020–2022 substance use response plan. Retrieved from https://dhhr.wv.gov
West Virginia Expert Pain Management Panel (WVEPMP). (2016). SEMP guidelines. Retrieved from http://sempguidelines.org
West Virginia, Office of Inspector General (WV OIG). (2019). Fact sheet: West Virginia’s oversight of opioid prescribing and monitoring of opioid use. Retrieved from https://oig.hhs.gov